Cargando...
Ascorbic acid: a promising agent in chronic kidney disease?
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, is related with impaired endothelial function and poor outcomes in chronic kidney disease (CKD) patients. In addition, oxidative stress and inflammation are also a common problem in CKD patients, and both have an impo...
Guardado en:
| Publicado en: | Clin Kidney J |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6070088/ https://ncbi.nlm.nih.gov/pubmed/30094017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfy044 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|